Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

27

Revenue 2017

Gilenya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gilenya was produced by Novartis.

Novartis still hungry after absorbing GSK oncology

Novartis still hungry after absorbing GSK oncology Among its fastest-growing products are oral multiple sclerosis therapy Gilenya (fingolimod), which climbed 26% to $638m in the first quarter, Tasigna (nilotinib) for chronic myeloid leukaemia brought in $372m, a

Novartis sees first benefits from efficiency drive

Novartis sees first benefits from efficiency drive Among the highlights of the year was Novartis' oral multiple sclerosis (MS) Gilenya (fingolimod), which climbed 32% to $666m in the fourth quarter and Tasigna (nilotinib) which brought in $428m, a

Novartis’ Gilenya fails in difficult-to-treat form of MS

Novartis’ Gilenya fails in difficult-to-treat form of MS Gilenya was approved in RRMS in 2010, revolutionising treatment in the area as the first oral drug to treat the condition. ... Novartis was hoping that Gilenya would provide a similar breakthrough in PPMS, although the data from INFORMS puts these

FDA adds rare brain infection link to Tecfidera labelling

FDA adds rare brain infection link to Tecfidera labelling patients. Biogen Idec said in its third-quarter results statement last month that Tecfidera is now the biggest-selling oral MS therapy - ahead of Novartis' Gilenya (fingolimod) and Sanofi's Aubagio

SMC recommends Novartis’ Gilenya for severe form of MS

SMC recommends Novartis’ Gilenya for severe form of MS Leads wave of drug reimbursement opinions in Scotland. Scotland has become the first country in the UK to recommend Gilenya (fingolimod) for patients with a severe form of relapsing multiple sclerosis.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics